ArticleOncoTargets and therapy2019

Upregulation Of miR-153 Inhibits Triple-Negative Breast Cancer Progression By Targeting ZEB2-Mediated EMT And Contributes To Better Prognosis.

Dongliang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.